Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)
CAPS Rating:
A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.
A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories.
Recs
Yield 2.46%. DGR 18%. PE 11. Normal PE 19. EPS Growth 21%. 13 year Dividend Contender. Undervalued. Position held in Brokerage account. Reinvesting dividends. Intend to increase position using cash dividend payouts from other stocks and new investment funds.